Phase II study of OK-432 intrapleural administration followed by systemic cisplatin and gemcitabine for non-small cell lung cancer with pleuritis carcinomatosa.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples